Company Profile

Vijaya Diagnostic Centre has informed that it enclosed a copy of the Compliance Certificate issued in terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2024 issued by Balaramakrishna Desina, Practicing Company Secretary.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Vijaya Diagnostic Centre has informed that it attached the details of ‘Investor Conference: Chasing Growth 2024’ organized by Kotak Institutional Equities’ on Thursday, 22nd February 2024 from 09:00 am (IST) in Mumbai, Maharashtra. The above information is also available on the website of the Company.

The above information is a part of company’s filings submitted to BSE.

Lupin’s consumer healthcare business -- LupinLife has launched Softovac Liquifibre, a 100% Ayurvedic liquid laxative. With this, the company enters the Indian liquid laxative market with this innovative product that is a formulation of Isabgol fibre in liquid form and natural actives such as Sonamukhi, Harad, Mulethi, Saunf, Amaltas and Gulab Dal.

Infosys has entered into a 5-year collaboration with LKQ Europe, one of the leading distributors of automotive aftermarket parts for cars, commercial vans, and industrial vehicles in Europe. Following multiple strategic acquisitions, LKQ has envisioned a corporate program that entails harmonizing business processes, improving product availability, and enabling faster delivery to end customers. Under this collaboration, Infosys will assist to integrate and standardize disparate business processes and systems, to enable synergies and achieve economies of scale.

Vijaya Diagnostic Centre has completed the acquisition of 100% stake by way of purchase of equity shares from its existing shareholders of P H Diagnostic Centre on December 21, 2023 for a cash consideration and as per the terms and conditions of the Share Purchase Agreement entered between the Company, P H Diagnostic Centre and the sellers. Post completion of the said acquisition, P H Diagnostic Centre has become a wholly-owned subsidiary (WOS) of the Company with effect from December 21, 2023. 

WPIL has received an order from PHED, Government of West Bengal for execution of a Turnkey Project for Package II of Surface based Water Supply Scheme, Northern Sector under Purulia District for an aggregate value of Rs 425.35 crore to be completed within a period of 27 months and 3 years operation and maintenance. The said order does not fall within related party transaction. 

Alfa Transformers has received purchase orders worth of Rs 3.28 crore from Rungta Sons and OCL Iron & Steel for Design, Manufacturing and Supply of 3.15MVA 11KV/0.433KV and 3.5 MVA and 3.0 MVA, 11/0.415KV, 3Phase, ONAN, Dyn 11, Copper wound Transformer with Off Load Tap Changer. The said order is expected to be completed by February 2024.

Tantia Constructions has secured an order worth Rs 68.48 crore from COMT Constructions against a contract work for ‘civil, structural, finishing works for UNIHOMES-03 (Phase-I), Noida’ with a completion period of 30 months. 

MAS Financial Services has raised Rs 25 crore through the allotment of 2500 Rated, Unsecured, Subordinated, Listed, Redeemable, Taxable, Transferable, Non-Convertible Debentures (NCDs) each having a face value of Rs 1,00,000 on a private placement basis. Further, these Debentures have been rated CARE A+ Positive (Single A Plus; Outlook: Positive) by CARE Ratings. The Finance Committee of Board of Directors of the Company at its meeting held on December 21, 2023, has approved and allotted the same. 

Vijaya Diagnostic Centre is currently trading at Rs. 653.70, up by 6.60 points or 1.02% from its previous closing of Rs. 647.10 on the BSE.

The scrip opened at Rs. 650.70 and has touched a high and low of Rs. 658.80 and Rs. 643.45 respectively. So far 4814 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 685.45 on 05-Dec-2023 and a 52 week low of Rs. 349.50 on 26-Apr-2023.

Last one week high and low of the scrip stood at Rs. 684.00 and Rs. 612.80 respectively. The current market cap of the company is Rs. 6620.39 crore.

The promoters holding in the company stood at 54.90%, while Institutions and Non-Institutions held 39.32% and 5.78% respectively.

Vijaya Diagnostic Centre has completed the acquisition of 100% stake by way of purchase of equity shares from its existing shareholders of P H Diagnostic Centre on December 21, 2023 for a cash consideration and as per the terms and conditions of the Share Purchase Agreement entered between the Company, P H Diagnostic Centre and the sellers. Post completion of the said acquisition, P H Diagnostic Centre has become a wholly-owned subsidiary (WOS) of the Company with effect from December 21, 2023. 

The company is one of the fastest-growing diagnostic chains in Southern India. It offers a one-stop solution for pathology and radiology testing services.